Finance

Lists
004720:KRX
PharmGen Science Inc
₩2,850.00
-1.21%
(-35.00) 1D
Oct 2, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 004720...
Open
₩2,880
High
₩2,900
Low
₩2,825
Mkt. cap
64.56B
Avg. vol.
15.52K
Volume
9.92K
52-wk high
₩4,485
52-wk low
₩2,590
EPS
-₩6,387
Shares outstanding
22.65M
No. of employees
239
Open
₩2,880
High
₩2,900
Low
₩2,825
Mkt. cap
64.56B
Avg. vol.
15.52K
Volume
9.92K
52-wk high
₩4,485
52-wk low
₩2,590
EPS
-₩6,387
Shares outstanding
22.65M
No. of employees
239
News stories
From web sources and news partners
About PharmGen Science Inc
CEOHee-Deok Park | Hye-Youn Kim
Employees239
FoundedAug 22, 1966
Headquarters-
SectorPharmaceutical industry
Websitepharmgenscience.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2024
Dec 2024
Mar 2025
Revenue
41.65B
44.23B
42.88B
Cost of goods sold
14.87B
16.24B
16.18B
Cost of revenue
14.87B
16.24B
16.18B
Research and development expenses
1.15B
1.15B
1.05B
Total research and development expenses
-
-
-
Selling, general, and admin expenses
22.10B
24.16B
23.00B
Operating expense
23.72B
26.15B
24.65B
Total operating expenses
38.59B
42.39B
40.83B
Operating income
3.06B
1.84B
2.04B
Other non operating income
-6.27B
10.62B
-849.07M
EBT including unusual items
-4.55B
996.02M
-665.17M
EBT excluding unusual items
-4.55B
4.07B
-665.17M
Income tax expense
-632.87M
-2.71B
44.99M
Effective tax rate
13.92%
-271.98%
-6.76%
Other operating expenses
26.14M
36.23M
42.13M
Net income
-3.91B
3.71B
-724.97M
Net profit margin
-9.39%
8.38%
-1.69%
Earnings per share
-
-
-
Interest and investment income
-
100.00M
-
Interest expense
-
-4.16B
-
Net interest expenses
-
-4.06B
-
Depreciation and amortization charges
303.02M
307.39M
305.70M
EBITDA
4.22B
2.99B
3.19B
Gain or loss from assets sale
-98.00K
1.84M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps